5-fluorouracil (5-FU) is a chemotherapy drug in Intro to Pharmacology that acts as a pyrimidine analog. It disrupts DNA and RNA synthesis, so rapidly dividing cancer cells cannot keep growing normally.
5-fluorouracil, usually called 5-FU, is an antineoplastic antimetabolite used in Intro to Pharmacology as a classic example of a drug that targets fast-dividing cells. It is a pyrimidine analog, which means it looks enough like a normal building block of nucleic acids to interfere with cell metabolism, but it does not let the cell make DNA and RNA correctly.
The big idea is that 5-FU works by mimicking uracil, one of the bases cells use when building RNA. Inside the body, it is converted into active metabolites that disrupt nucleotide synthesis and interfere with thymidylate synthase, an enzyme needed to make thymidine for DNA production. Without enough thymidine, cells cannot copy DNA efficiently, so cells in the middle of division are the most vulnerable.
That is why 5-FU is used in cancer treatment. Tumor cells tend to divide more quickly than most normal cells, so they are more sensitive to drugs that interrupt DNA replication. In practice, 5-FU is especially common in colorectal cancer regimens, but it can also show up in treatment plans for other solid tumors.
Pharmacology courses usually connect 5-FU to the broader logic of antimetabolites: these drugs do not just poison a tumor by one blunt mechanism, they interfere with the chemistry of growth itself. That is also why 5-FU is often given in combination chemotherapy. Pairing it with other drugs can increase cancer cell kill by hitting the tumor at more than one point in the cell cycle or by improving how strongly the regimen works.
A detail that shows up a lot in class is toxicity. Because 5-FU affects rapidly dividing cells, side effects often involve tissues that renew quickly, such as the lining of the gut and bone marrow. Nausea, vomiting, diarrhea, and myelosuppression are common examples. The drug can also be given intravenously, and in some cases topically for certain skin cancers, which is a good reminder that route of administration depends on the clinical goal and the tissue being treated.
Leucovorin is another term that often comes up beside 5-FU. It can enhance the drug's effect in certain regimens, so if you see the two together, think combination therapy and a stronger antitumor response rather than two unrelated medications.
5-fluorouracil matters because it is one of the clearest examples of how pharmacology turns basic cell biology into treatment. If you understand 5-FU, you understand a lot of antineoplastic drug logic at once: selective toxicity, interference with nucleotide synthesis, and the tradeoff between killing tumor cells and harming healthy fast-dividing tissue.
It also helps you interpret why chemotherapy regimens are built the way they are. 5-FU is rarely used as a stand-alone idea in class or in the clinic. It is usually discussed with combination chemotherapy, leucovorin, adverse effects, and monitoring, so the term opens the door to the larger unit on cancer treatment.
This drug is also a good checkpoint for mechanism questions. If a quiz asks whether a drug blocks DNA replication, acts as an antimetabolite, or mimics a pyrimidine base, 5-FU is the kind of example you are expected to recognize. That makes it useful not just as a name to memorize, but as a model for how antineoplastic agents are classified and why they work the way they do.
In patient-centered cases, 5-FU helps you connect mechanism to side effects and route of administration. If a case mentions colorectal cancer plus diarrhea, mouth sores, or low blood counts after treatment, that pattern fits the drug's effects on rapidly dividing cells. Seeing that connection is a core pharmacology skill.
Keep studying Intro to Pharmacology Unit 10
Visual cheatsheet
view galleryAntimetabolite
5-fluorouracil is an antimetabolite, so it works by interfering with the cell's normal building blocks rather than by directly blasting tissue. In class, this connection helps you group 5-FU with drugs that mimic natural molecules and disrupt DNA or RNA production. If you remember that antimetabolites target nucleotide metabolism, 5-FU becomes easier to place.
Leucovorin
Leucovorin often appears with 5-FU in combination chemotherapy. It can increase the effectiveness of 5-FU in certain treatment regimens, so the two are commonly taught together. If you see both names in a case or drug list, the question is usually about why the combination improves cancer control rather than about each drug separately.
Combination Chemotherapy
5-fluorouracil is a textbook example of a drug used in combination chemotherapy. The point of the combination is to attack the cancer in more than one way and reduce the chance that one pathway can keep the tumor alive. When you study 5-FU, you are also seeing why oncology often uses multi-drug regimens instead of one medication alone.
Pharmacokinetics
Pharmacokinetics matters for 5-FU because route, dosing schedule, and monitoring affect both benefit and toxicity. In Intro to Pharmacology, you may be asked why a drug is given intravenously, how long it stays active, or why side effects appear in certain tissues. Those questions link 5-FU to absorption, distribution, metabolism, and excretion.
Quiz questions and case prompts usually ask you to identify 5-fluorouracil from its mechanism, not just its name. You might see a stem about a colorectal cancer drug that mimics uracil, inhibits DNA synthesis, and causes diarrhea or myelosuppression. The task is to connect the mechanism with the side effects and choose the antimetabolite category.
On problem sets or short-answer exams, you may be asked why 5-FU is effective against cancer cells that divide quickly, or why it is paired with leucovorin in a regimen. In a drug chart, you should be able to name its class, typical route, major toxicity, and one common clinical use. If the instructor gives a case, trace the symptom pattern back to the fact that the drug hits rapidly dividing normal tissues as well as tumor cells.
5-fluorouracil is an antimetabolite chemotherapy drug that interferes with DNA and RNA synthesis.
It acts as a pyrimidine analog, meaning it resembles a normal nucleic acid building block but disrupts cell replication instead of supporting it.
In Intro to Pharmacology, 5-FU is a classic example of a drug used against rapidly dividing cancer cells, especially in colorectal cancer.
Common side effects come from damage to other fast-growing tissues, so nausea, diarrhea, and myelosuppression are expected toxicities.
5-FU often appears in combination chemotherapy, and leucovorin can enhance its effect in certain regimens.
5-fluorouracil, or 5-FU, is a chemotherapy drug in the antimetabolite class. It blocks DNA and RNA synthesis by mimicking a normal pyrimidine base, so cancer cells cannot divide normally. It is especially associated with treatment of colorectal cancer and other solid tumors.
5-fluorouracil is a pyrimidine analog. That means it resembles uracil, one of the pyrimidine bases used in nucleic acids. This is why it disrupts nucleotide metabolism and interferes with DNA and RNA production.
5-FU affects rapidly dividing cells, not just cancer cells. The intestinal lining and bone marrow also divide quickly, so they are common sites of toxicity. That is why gastrointestinal effects and low blood cell counts show up so often in pharmacology cases.
Leucovorin can enhance the antitumor effect of 5-FU in some treatment regimens. In class, this usually comes up as an example of combination chemotherapy, where one drug strengthens the overall response rather than acting as a separate cancer drug on its own.